SUBCLINICAL IMMUNE CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS

Clinical trials for SUBCLINICAL IMMUNE CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS explained in plain language.

Never miss a new study

Get alerted when new SUBCLINICAL IMMUNE CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS trials appear

Sign up with your email to follow new studies for SUBCLINICAL IMMUNE CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New scan could spot hidden heart damage before It's too late

Diagnosis Recruiting now

This study is testing whether PET scans can detect early, hidden heart inflammation in cancer patients receiving immunotherapy drugs. Researchers want to see if these scans can identify patients at risk for developing serious heart complications before symptoms appear. The study …

Matched conditions: SUBCLINICAL IMMUNE CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS

Sponsor: Mayo Clinic • Aim: Diagnosis

Last updated Mar 24, 2026 12:02 UTC

SUBCLINICAL IMMUNE CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS

Get alerted when new SUBCLINICAL IMMUNE CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS trials appear

New scan could spot hidden heart damage before It's too late